Sanofi Forms Standalone Consumer Healthcare Unit: Prelude To Spin-Off?
Executive Summary
Sanofi Consumer Healthcare is to operate as a standalone unit in a move which is being viewed as a prelude to a potential spin-off. High profile prescription-to-OTC switches are a priority for the revamped business.
You may also be interested in...
US OTC Switch For Cialis At Top Of To-Do List For Sanofi’s North American Consumer Health Chief
Andrew Loucks moves to Sanofi from helm of consumer health and technology firm Sensory Cloud as business navigates gaining US OTC heartburn market share for Zantac brand, which it relaunched with famotidine replacing ranitidine as the active ingredient.
GSK Exits Consumer Health With Haleon Launch
The global market leader in consumer health is now Haleon following its separation from GSK after more than two years of planning.
Sanofi Starting US Cialis OTC Actual Use Study Soon While Tamiflu Switch Progress Delayed
After 118.2% cough/cold sales growth leads 17% overall consumer business growth, Sanofi points to still stronger days ahead while keeping the business under the same roof with its pharmaceutical and vaccine divisions.